GCFRX
Price
$10.30
Change
+$0.01 (+0.10%)
Updated
Jun 2 closing price
Net Assets
237.33M
SAUPX
Price
$13.04
Change
+$0.03 (+0.23%)
Updated
Jun 2 closing price
Net Assets
2.18B
Interact to see
Advertisement

GCFRX vs SAUPX

Header iconGCFRX vs SAUPX Comparison
Open Charts GCFRX vs SAUPXBanner chart's image
GCFRX vs SAUPX Comparison Chart in %
View a ticker or compare two or three
VS
GCFRX vs. SAUPX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCFRX is a StrongBuy and SAUPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SAUPX has more cash in the bank: 2.18B vs. GCFRX (237M). GCFRX pays higher dividends than SAUPX: GCFRX (3.22) vs SAUPX (2.85). GCFRX was incepted earlier than SAUPX: GCFRX (23 years) vs SAUPX (30 years). GCFRX (1.21) is less costly to investors than SAUPX (1.00). GCFRX is a more actively managed with annual turnover of: 32.77 vs. SAUPX (23.90). GCFRX has a lower initial minimum investment than SAUPX: GCFRX (0) vs SAUPX (1000). SAUPX annual gain was more profitable for investors over the last year : 9.71 vs. GCFRX (8.65). SAUPX return over 5 years is better than : 10.36 vs. GCFRX (7.77).
GCFRXSAUPXGCFRX / SAUPX
Total Expense Ratio1.211.00121%
Annual Report Gross Expense Ratio1.211.00121%
Fund Existence23 years30 years-
Gain YTD2.9193.31088%
Front LoadN/A4%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets237M2.18B11%
Annual Yield % from dividends3.222.85113%
Returns for 1 year8.659.7189%
Returns for 3 years17.9926.1169%
Returns for 5 years7.7710.3675%
Returns for 10 years27.6339.3470%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CARR66.421.31
+2.01%
Carrier Global Corp
PASG5.950.10
+1.71%
Passage Bio Inc
EE32.740.12
+0.37%
Excelerate Energy
OLLI79.24-1.62
-2.00%
Ollie's Bargain Outlet Holdings
KROS10.52-0.38
-3.49%
Keros Therapeutics